HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yao Zhu Selected Research

Sunitinib (Sutent)

5/2016Oligometastatic state predicts a favorable outcome for renal cell carcinoma patients with bone metastasis under the treatment of sunitinib.
9/2013[Exploratory analysis of the effect of toxicity of sunitinib on the clinical outcome of patients with advanced renal cell carcinoma].
3/2013[Hematologic adverse effects in patients with renal cell carcinoma treated with sunitinib].
1/2010Feasibility and activity of sorafenib and sunitinib in advanced penile cancer: a preliminary report.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yao Zhu Research Topics

Disease

93Prostatic Neoplasms (Prostate Cancer)
04/2024 - 01/2007
82Neoplasms (Cancer)
04/2024 - 11/2008
30Renal Cell Carcinoma (Grawitz Tumor)
01/2020 - 07/2009
26Penile Neoplasms (Penile Cancer)
10/2023 - 07/2007
17Neoplasm Metastasis (Metastasis)
04/2024 - 06/2008
12Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2023 - 07/2007
11Infections
05/2024 - 01/2019
9Urinary Bladder Neoplasms (Bladder Cancer)
01/2022 - 01/2008
9Lymphatic Metastasis
03/2016 - 07/2007
8Alzheimer Disease (Alzheimer's Disease)
08/2023 - 01/2017
7Inflammation (Inflammations)
01/2024 - 01/2019
6Carcinoma (Carcinomatosis)
01/2023 - 09/2015
5Disease Progression
03/2024 - 01/2007
5Cardiovascular Diseases (Cardiovascular Disease)
01/2022 - 05/2015
5Hypertension (High Blood Pressure)
01/2020 - 01/2012
4Obesity
02/2023 - 01/2016
4Carcinogenesis
01/2022 - 11/2014
4Adenocarcinoma
01/2022 - 01/2017
4Cognitive Dysfunction
01/2021 - 01/2019
3Breast Neoplasms (Breast Cancer)
03/2024 - 09/2022
3Fibrosis (Cirrhosis)
01/2024 - 01/2020
3Body Weight (Weight, Body)
02/2023 - 01/2020
2Metabolic Bone Diseases (Osteopenia)
03/2024 - 01/2023
2Sepsis (Septicemia)
03/2024 - 04/2023
2Birth Weight (Birth Weights)
03/2024 - 01/2023
2Anemia
03/2024 - 06/2011
2Newborn Respiratory Distress Syndrome
03/2024 - 01/2021
2Cholestasis
03/2024 - 01/2023
2Mitochondrial Diseases (Mitochondrial Disease)
01/2024 - 01/2020
2Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL)
12/2023 - 08/2022
2Lung Neoplasms (Lung Cancer)
08/2023 - 01/2023
2Hyperlipidemias (Hyperlipidemia)
02/2023 - 09/2018
2Bone Resorption
08/2022 - 01/2022

Drug/Important Bio-Agent (IBA)

26Prostate-Specific Antigen (Semenogelase)IBA
01/2023 - 06/2008
20Biomarkers (Surrogate Marker)IBA
04/2024 - 01/2008
15Proteins (Proteins, Gene)FDA Link
02/2024 - 01/2008
13AndrogensIBA
10/2022 - 07/2010
11Hormones (Hormone)IBA
12/2023 - 01/2007
8Messenger RNA (mRNA)IBA
01/2024 - 01/2008
7AntigensIBA
04/2024 - 05/2017
7Sorafenib (BAY 43-9006)FDA Link
10/2016 - 07/2009
6LipidsIBA
02/2023 - 03/2015
6Docetaxel (Taxotere)FDA Link
09/2017 - 01/2007
5Apolipoproteins E (ApoE)IBA
08/2023 - 01/2019
5ApolipoproteinsIBA
08/2023 - 05/2015
5Glucose (Dextrose)FDA LinkGeneric
02/2023 - 09/2018
5abirateroneIBA
01/2023 - 03/2018
5CytokinesIBA
07/2022 - 01/2014
4VaccinesIBA
12/2024 - 01/2021
4Indicators and Reagents (Reagents)IBA
11/2022 - 01/2015
4EnzymesIBA
01/2022 - 04/2013
4oxidized low density lipoproteinIBA
01/2021 - 05/2014
4Sunitinib (Sutent)FDA Link
05/2016 - 01/2010
4AdiponectinIBA
01/2016 - 11/2014
3Androgen Receptors (Androgen Receptor)IBA
04/2024 - 08/2014
3DNA (Deoxyribonucleic Acid)IBA
04/2024 - 01/2019
3Triglycerides (Triacylglycerol)IBA
03/2024 - 05/2014
3Peptides (Polypeptides)IBA
02/2024 - 09/2015
3Netrin-1IBA
12/2023 - 01/2022
3Anti-Bacterial Agents (Antibiotics)IBA
01/2023 - 12/2021
3AlbuminsIBA
10/2021 - 06/2011
3HDL CholesterolIBA
01/2021 - 09/2018
3enzalutamideIBA
10/2020 - 01/2019
3CholesterolIBA
11/2019 - 05/2014
3MicroRNAs (MicroRNA)IBA
12/2017 - 02/2011
3Prednisone (Sone)FDA LinkGeneric
02/2014 - 01/2007
2Anti-Infective Agents (Microbicides)IBA
05/2024 - 01/2023
2Radioisotopes (Radionuclides)IBA
04/2024 - 01/2022
2Transcription Factors (Transcription Factor)IBA
04/2024 - 02/2016
2Reactive Oxygen Species (Oxygen Radicals)IBA
03/2024 - 01/2020
2EmulsionsIBA
03/2024 - 01/2023
2arginyl-glycyl-aspartic acidIBA
02/2024 - 04/2021
2lysylglycineIBA
02/2024 - 04/2021
2Netrin ReceptorsIBA
12/2023 - 08/2022
2ORALIT (ORS)IBA
03/2023 - 01/2018
2Hematoxylin (Haematoxylon)IBA
02/2023 - 10/2019
2Eosine Yellowish-(YS) (Eosin)IBA
02/2023 - 10/2019
2NucleotidesIBA
02/2023 - 01/2023
2B7-H1 AntigenIBA
01/2023 - 01/2019
2Immunoglobulins (Immunoglobulin)IBA
01/2023 - 01/2017

Therapy/Procedure

43Therapeutics
04/2024 - 06/2008
26Castration
04/2024 - 11/2009
21Prostatectomy (Retropubic Prostatectomy)
06/2021 - 11/2010
19Lymph Node Excision (Lymph Node Dissection)
10/2023 - 02/2008
11Drug Therapy (Chemotherapy)
10/2021 - 01/2010
8Chinese Traditional Medicine (Traditional Chinese Medicine)
08/2023 - 04/2013
8Radiotherapy
01/2022 - 01/2012
8Nephrectomy
01/2019 - 07/2009
5Cystectomy
11/2015 - 01/2009
4Microbubbles
03/2024 - 04/2021
4Precision Medicine
02/2024 - 01/2018
3Blood Transfusion (Blood Transfusions)
03/2024 - 04/2010
3Immunotherapy
01/2023 - 01/2022
3Aftercare (After-Treatment)
08/2022 - 01/2010
3Operative Surgical Procedures
10/2021 - 03/2015
3Neoadjuvant Therapy
01/2020 - 06/2012
3Transurethral Resection of Prostate (TURP)
01/2017 - 08/2011
3Adjuvant Chemotherapy
01/2017 - 09/2015
2Parenteral Nutrition
03/2024 - 01/2023
2Critical Care (Surgical Intensive Care)
04/2023 - 07/2021